Macrophage-mediated axonal dieback presents an additional challenge to regenerating axons after spinal cord injury. Adult adherent stem cells are known to have immunomodulatory capabilities, but their potential to ameliorate this detrimental inflammation-related process has not been investigated. Using an in vitro model of axonal dieback as well as an adult rat dorsal column crush model of spinal cord injury, we found that multipotent adult progenitor cells (MAPCs) can affect both macrophages and dystrophic neurons simultaneously. MAPCs significantly decrease MMP-9 (matrix metalloproteinase-9) release from macrophages, effectively preventing induction of axonal dieback. MAPCs also induce a shift in macrophages from an M1, or "classically activated" proinflammatory state, to an M2, or "alternatively activated" antiinflammatory state. In addition to these effects on macrophages, MAPCs promote sensory neurite outgrowth, induce sprouting, and further enable axons to overcome the negative effects of macrophages as well as inhibitory proteoglycans in their environment by increasing their intrinsic growth capacity. Our results demonstrate that MAPCs have therapeutic benefits after spinal cord injury and provide specific evidence that adult stem cells exert positive immunomodulatory and neurotrophic influences.
Introduction
Minimal regeneration occurs spontaneously after injury to the CNS, and therefore, it is critical to identify strategies that can halt loss of function and/or promote recovery (Tator, 2006; Eftekharpour et al., 2008) . Traumatic spinal cord injury initiates a complex series of events leading to secondary injury and formation of a glial scar . Previous work from our laboratory has shown that the infiltration of phagocytic ED1ϩ macrophages coincides with long-distance axonal retraction, or dieback, from the initial site of a spinal cord lesion, resulting in a disadvantageous starting position for regenerating axons . Injured axons that become dystrophic because of the presence of inhibitory proteoglycans in their environment are particularly susceptible to attack by macrophages. In addition to the relative permissiveness of the substrate on which the axon is growing, several factors can affect the outcome of macrophage attack, including enhancement of the intrinsic growth potential of the neuron and alteration of macrophage-secreted factors (Busch et al., 2009 ). In addition, we have shown that macrophagemediated axonal dieback can be prevented in vitro by specific inhibition of matrix metalloproteinase-9 (MMP-9). Additionally, endogenous stem-like NG2ϩ progenitor cells that normally populate the lesion center can stabilize axons undergoing axonal dieback because of their expression of growth-promoting extracellular matrix molecules but cannot prevent the initiation of dieback (Busch et al., 2010) .
In the past decade, adult stem cells have been isolated from multiple tissues and characterized in many laboratories (Mays et al., 2007; Ting et al., 2008) . There is substantial interest in developing adult-derived stem cells as therapeutic agents for the treatment of CNS injury and disease (Biernaskie et al., 2007; Bambakidis et al., 2008; Barnabé-Heider and Frisén, 2008) . Adult-derived adherent stem cells demonstrate a number of favorable characteristics including genetic stability, extensive expansion capacity, and low immunogenicity profiles that support allogeneic utility (Gnecchi et al., 2008) . Functional improvement after administration of adult-derived cells has been demonstrated in multiple preclinical models of injury or disease; however, many aspects of their mechanism of action remain poorly understood (Caplan and Dennis, 2006) . Additional investigation of the specific mechanisms underlying the beneficial effects after treatment with adult stem cells will be important as cellular therapeutics enter clinical development.
Multipotent adult progenitor cells (MAPCs) are a well characterized population of adherent stem cells isolated from adult bone marrow and other adult tissues (Jiang et al., 2002a,b) that can positively modulate the immune system (Kovacsovics- Bankowski et al., 2009) . MAPCs are one of several populations of stem cells isolated from the bone marrow compartment, such as mesenchymal stem cells (MSCs) and marrow-isolated adult multilineage inducible (MIAMI) cells (Mays et al., 2007) . Both MAPCs and MSCs have been shown to have strong immunomodulatory properties, and MAPCs are capable of extensive expansion in culture (Jiang et al., 2002b) . Because of our previous observations of the negative effects of macrophages after injury, we sought to determine whether MAPCs could affect immune cells responding to the initial insult to prevent axonal dieback and promote regeneration.
Materials and Methods
Dorsal root ganglion neuron preparation. Dorsal root ganglia (DRGs) were harvested as previously described (Tom et al., 2004) . Briefly, DRGs were dissected out of adult female Sprague Dawley rats (Harlan). Both the central and peripheral roots were removed and ganglia incubated in a solution of collagenase II (200 U/ml; Worthington) and dispase II (2.5 U/ml; Roche) in HBSS. The digested DRGs were rinsed and gently triturated in fresh calcium-and magnesium-free HBSS (HBSS-CMF) three times followed by low-speed centrifugation. The dissociated DRGs were then resuspended in Neurobasal A medium supplemented with B-27, Glutamax, and penicillin/streptomycin (all from Invitrogen) and counted. DRGs were plated on Delta-T dishes (Thermo Fisher Scientific) at a density of 3000 cells/ml for a total of 6000 cells/dish.
Time-lapse dish preparation. Delta-T cell culture dishes (Thermo Fisher Scientific) were prepared as described previously . Briefly, a single hole was drilled through the upper half of each dish to create a port for the addition of cells to the cultures during time-lapse microscopy. Dishes were then rinsed with sterile water and coated with poly-L-lysine (0.1 mg/ml; Invitrogen) overnight at room temperature. Dishes were then rinsed with sterile water and allowed to dry. Aggrecan gradient spots were created by pipetting 2.0 l of aggrecan solution (2.0 mg/ml; Sigma-Aldrich; in HBSS-CMF; Invitrogen) onto the culture surface and allowed to dry. Six spots were placed per dish. After the aggrecan spots dried completely, the entire surface of the dish was bathed in laminin solution (10 g/ml; BTI; in HBSS-CMF) for 3 h at 37°C. The laminin bath was then removed immediately before plating of cells.
Rat macrophage cultures. NR8383 cells (ATCC; CRL-2192), an adult Sprague Dawley alveolar macrophage cell line, were cultured as described in previously (Yin et al., 2003) . Briefly, cells were cultured in uncoated tissue culture flasks (Corning) in F-12K medium (Invitrogen) supplemented with 15% FBS (Sigma-Aldrich), Glutamax, Penn/Strep (Invitrogen), and sodium bicarbonate (Sigma-Aldrich), and fed two to three times per week. To prepare the cell line macrophages for time-lapse microscopy experiments, cells were harvested with trypsin/EDTA (Invitrogen), washed three times, and plated in uncoated tissue culture flasks at a density of 1.0 ϫ 10 6 /ml in serum-free F-12K. Before use in time-lapse experiments, the cultured cell line macrophages were harvested with EDTA and a cell scraper and resuspended in Neurobasal A with the addition of HEPES (50 M; Sigma-Aldrich) at a density of 2.5 ϫ 10 5 /70 l. Astrocyte culture. Cortical astrocytes were collected by removing the cortices from postnatal day 1 rats, which were then finely minced and treated with 0.5% trypsin/EDTA (Sigma-Aldrich). Cells were seeded in DMEM/F12 medium supplemented with 10% fetal bovine serum (FBS), 2 mM Glutamax, 100 U/ml penicillin, and 100 g/ml streptomycin (all from Invitrogen) on T75 flasks coated with poly-L-lysine, and shaken after 4 h to remove nonadherent cells. Astrocytes were considered mature after they were maintained in culture for 35 d.
MAPC cultures. Sprague Dawley green fluorescent protein (GFP) rat MAPCs were prepared as described previously ( Van't Hof et al., 2007) . Rat MAPCs were originally generated by Dr. Felipe Prosper at the University of Navarra (Pamplona, Spain) and subsequently transduced with a GFP retrovirus in the laboratory of Dr. Catherine Verfaillie at the University of Minnesota (Minneapolis, MN). Sprague Dawley rat GFPϩ MAPCs were expanded, banked, and evaluated by Athersys, Inc. In brief, the parental rat MAPC lines were acquired from two to four male rat donors. Cells were grown in medium consisting of low-glucose DMEM (Invitrogen), 0.4ϫ MCDB-201 medium (Sigma-Aldrich), 1ϫ ITS liquid medium supplement (Sigma-Aldrich), 1 mg/ml linoleic acid-albumin (Sigma-Aldrich), 100 U/ml penicillin G sodium/100 g/ml streptomycin sulfate (Invitrogen), 100 M 2-P-L-ascorbic acid (Sigma-Aldrich), 100 ng/ml EGF (epidermal growth factor) (Sigma-Aldrich), 100 ng/ml PDGF (R&D Systems), 50 nM dexamethasone (Sigma-Aldrich), 1000 U/ml ESGRO (Millipore Bioscience Research Reagents), and 2% fetal bovine serum (HyClone). Marrow cells were resuspended in growth medium, viable cells were subsequently plated in fibronectin-coated (10 ng/ml; Invitrogen) 150 cm 2 tissue culture flasks (Corning), and after 24 h all nonadherent cells were removed. After 14 d, all colonies were trypsinized, combined, and replated at 75% confluence. The cells were maintained in 15 ml of medium/flask at 37°C and 5.0% CO 2 with passaging every 3-4 d using trypsin/EDTA (Invitrogen), when at 30 -40% confluence, and reseeded at 500 -1000 cells/cm 2 . Flow cytometric analysis of surface-expressed antigens confirmed that MAPCs used in this study are a homogeneous cell population. They are positive for CD29, CD90, CD44, and MHC class I, and are negative for MHC class II, CD45, CD106, and the costimulatory molecules CD80 and CD86, indicating that these cells are not derived from the hematopoietic lineage.
MAPC-conditioned medium. Cells were cultured as described above, and conditioned medium was collected after 48 h in 50 ml conical tubes (BD Biosciences). The conditioned medium was spun down at 400 ϫ g for 5 min at 4°C, and the supernatant was transferred to a new 50 ml conical tube. MAPC-conditioned medium (MAPC-CM) was obtained as described above and concentrated 50-fold with an Amicon Microcon Ultracel YM-3 3000 MWCO centrifugal filter (Millipore).
MAPC-conditioned medium-treated macrophages. NR8383 rat macrophages were cultured as described above. One day before time-lapse microscopy experiments, macrophages were harvested with trypsin/ EDTA (Invitrogen), washed three times, and plated in uncoated tissue culture flasks at a density of 1.0 ϫ 10 6 /ml in serum-free F-12K. Twenty microliters of the 50-fold concentrated MAPC-conditioned medium were added per 1 ml of serum-free F-12K medium, for a final concentration of 1ϫ. Before use in time-lapse experiments, the cultured cell line macrophages were harvested with EDTA and a cell scraper and resuspended in Neurobasal A with the addition of HEPES (50 M; SigmaAldrich) at a density of 2.5 ϫ 10 5 /70 l. Time-lapse microscopy. DRG neurons were incubated at 37°C for 48 h before time-lapse imaging. Neurobasal A medium with HEPES (50 M; Sigma-Aldrich) was added to the culture before transfer to a heated stage apparatus. Time-lapse images were acquired every 30 s for 3 h with a Zeiss Axiovert 405M microscope using a 100ϫ oil-immersion objective. Growth cones were chosen that extended straight into the spot rim and had characteristic dystrophic morphology for 30 min to observe baseline behavior before the addition of cells or conditioned medium and then observed for 3 h. For cell addition experiments, cultured rat-derived MAPCs were harvested from tissue culture flasks, washed three times, and resuspended in Neurobasal A medium. For coculture experiments, MAPCs (100,000/dish) were added to dorsal root ganglia neuron cultures after 24 h and incubated at 37°C for 24 additional hours before time-lapse imaging. For experiments in which MAPC-CM was added to DRG cultures during time-lapse imaging, 90 l of 50ϫ MAPC-CM was added after 30 min of baseline growth cone observation. MAPC-CMtreated macrophages were added to time-lapse cultures after 30 min of baseline imaging (500,000 cells/dish). Extension/retraction, rate of growth, turning, and branching were analyzed using MetaMorph software.
Immunocytochemistry. After time-lapse imaging, DRGs were fixed in 4% paraformaldehyde (PFA) and immunostained with anti-B-tubulintype III (1:500; Sigma-Aldrich), anti-chondroitin sulfate (CS-56; 1:500; Sigma-Aldrich), and anti-GFP (1:500; Invitrogen).
MMP-9 assays. NR8383 cells were cultured as described above, but in 24-well plates at an initial density of 100,000 cells/cm 2 . MAPCs were cocultured with the NR8383 cells, via Transwells (0.4 m; Costar), at an equal plating density. Negative control wells also received Transwell inserts, with an equivalent volume of medium, but no addition of MAPCs.
After 24 h, the Transwells and MAPCs were removed and discarded. NR8383 culture medium was removed, and the NR8383 cells were washed three times with PBS and refed with fresh medium containing no FBS. After an additional 24 h, the NR8383 conditioned medium was collected for Western blot and zymogram analyses, and NR8383 total RNA was harvested for quantitative PCR analysis.
Western blotting. Total conditioned medium from two replicate wells was concentrated using the described centrifugal filters to a final volume of ϳ20 l. The total concentrated volume was loaded onto a 10% polyacrylamide gel (Bio-Rad; each gel lane represents total conditioned medium concentrated from two replicate wells), electrophoresed for 1-2 h at 100 V, and transferred to polyvinylidene difluoride membrane (Immobilon membrane; Millipore). Western blots were blocked in Western Blocking Solution (Sigma-Aldrich) for 30 min, and then incubated in primary antibody (␣-MMP-9; AB19016; Millipore; 1:1000 dilution in blocking solution) for 2 h at room temperature. Western blots were washed four times in TBS and incubated in secondary antibody (␣-rabbit IgG HRP; Promega; 1:2500 dilution in blocking solution) for 1 h at room temperature. Bound HRP-conjugated antibody was visualized using ECL chemiluminescence reagent (GE Healthcare) according to manufacturer's specifications, and imaged using a ChemiDoc-It imaging system (UVP). Background-subtracted band densitometry was measured and analyzed by Student's t test for statistical significance.
Zymography. Total conditioned medium from two replicate wells was concentrated as described above and loaded onto a 10% gelatin zymogram gel (Bio-Rad) and electrophoresed for 1-2 h at 100 V. Zymograms were washed in 2.5% Triton X-100 for 30 min and incubated overnight at 37°C in developing buffer (50 mM Tris, 200 mM NaCl, 5 mM CaCl 2 , 0.02% Brij35). Zymograms were stained for 1 h (0.5% Coomassie G250, 30% methanol, 10% acetic acid) and destained (30% methanol, 10% acetic acid) until bands were visualized. Zymograms were brightfield imaged using a ChemiDoc-It imaging system. Background-subtracted band densitometry was measured and analyzed by Student's t test for statistical significance.
Quantitative PCR. RNA was isolated from NR8383 cells using RNEasy columns (QIAGEN) according to manufacturer's specifications. Rat reference RNA (Stratagene) was used as a positive control. Synthesis of cDNA was performed with M-MLV (Moloney murine leukemia virus) reverse transcriptase and random hexamers (Promega). Control reactions were performed without reverse transcriptase to control for genomic DNA contamination. SYBR Green quantitative PCR was performed using the following primers: MMP-9 forward, GCGCCAGC-CGACTTATGT; MMP-9 reverse, AATCCTCTGCCAGCTGTGTGT; ␤-actin forward, AGCCCCCTCTGAACCCTAAG; ␤-actin reverse, CAACACAGCCTGGATGGCTAC; rat Arg1 forward, CAG CAG GAA CCC TGG ATG A; rat Arg1 reverse, AAA GGC GCT CCG ATA ATC TCT; rat iNOS forward, CAT CAG GTC GGC CAT TAC TGT; rat iNOS reverse, CCA GAT CCG GAA GTC ATG CT. Quantitative PCR was performed using an ABI 7500 with 9600 emulation. The PCR conditions were 50°C for 2 min, 95°C for 10 min, and then 40 cycles of 95°C for 15 s, 60°C for 1 min. NR8383 MMP-9 quantitation was normalized to ␤-actin levels and expressed as percentage of rat reference MMP-9 signal.
Dorsal column crush lesion model. All animal procedures were performed in accordance with the guidelines and protocols of the Animal Resource Center at Case Western Reserve University. Adult female Sprague Dawley rats, 250 -300 g, were anesthetized with inhaled isoflurane gas (2%) for all surgical procedures. A T1 laminectomy was performed to expose the dorsal aspect of the C8 spinal cord segment. A durotomy was made bilaterally 0.75 mm from midline with a 30 gauge needle. A dorsal column crush lesion was then made by inserting Dumont no. 3 jeweler's forceps into the dorsal spinal cord at C8 to a depth of 1.0 mm, squeezing the forceps, holding pressure for 10 s, and repeating two additional times. Completion of the lesion was verified by observation of white matter clearing. The holes in the dura were then covered with gel film. The muscle layers were sutured with 4-0 nylon suture, and the skin was closed with surgical staples. On closing of the incision, animals received Marcaine (1.0 mg/kg) subcutaneously along the incision as well as buprenorphine (0.1 mg/kg) intramuscularly. Postoperatively, animals were kept warm with a heating lamp during recovery from anesthesia and allowed access to food and water ad libitum. Animals were killed at 2, 4, or 7 d after lesion.
Cell transplantation. Cultured rat-derived MAPCs were harvested from tissue culture flasks, washed three times in HBSS-CMF, and resuspended in HBSS-CMF at a density of 200,000 cells/l. For astrocyte transplants, cells were labeled using Vybrant CFDA SE Cell Tracer Kit (Invitrogen) at 10 M for 15 min at 37°C and washed twice before resuspension in HBSS-CMF at a density of 200,000 cells/l. Immediately after dorsal column crush injury, 1.0 l of the cell suspension was injected unilaterally 0.5 mm deep into the right side dorsal columns. The injection site was 0.5 mm lateral to the midline and 0.5 mm caudal to the lesion edge. The cells were injected with 44 23.0 nl pulses on 15 s intervals through a pulled glass pipette attached to a Nanoject II (Drummond). The glass pipette was then withdrawn from the spinal cord 2 min after the final injection. After the transplantation, the injection site was covered with gelfilm, the muscle layers were closed with 4-0 ethicon sutures, and the skin was closed with surgical staples. Postoperatively, animals were kept warm with a heating lamp during recovery from anesthesia and allowed access to food and water ad libitum. Animals were killed 2 or 4 or 7 d after lesion.
Axon labeling. Two days before rats were killed, the dorsal columns were labeled unilaterally with Texas Red-conjugated 3000 molecular weight (MW) dextran. Briefly, the sciatic nerve of the right hindlimb was exposed and crushed three times with Dumont no. 3 forceps for 10 s. One microliter of 3000 MW dextran-Texas Red (10%) in sterile water was the injected via a Hamilton syringe into the sciatic nerve at the crush site. The muscle layers were closed with 4-0 nylon suture and the skin with surgical staples. On closing of the incision, animals received Marcaine (1.0 mg/kg) subcutaneously along the incision as well as buprenorphine (0.1 mg/kg) intramuscularly. Postoperatively, animals will be kept warm with a heating lamp during recovery from anesthesia and allowed access to food and water ad libitum. Animals were killed 2 d after labeling with an overdose of isoflurane and perfused with PBS followed by 4% PFA. Tissue was harvested and postfixed in 4% PFA and processed for immunohistochemistry.
Immunohistochemistry. Tissue was postfixed in 4% PFA overnight and then submersed in 30% sucrose overnight, frozen in OTC mounting medium, and cut on a cryostat into 20 m longitudinal sections. Tissue was then stained with anti-ED1/Alexa Fluor 633, anti-GFP/Alexa Fluor 488, and anti-vimentin/Alexa Fluor 488, and imaged on a Zeiss Axiovert 510 laser-scanning confocal microscope at 10ϫ magnification.
Axonal dieback quantification. To quantify axonal dieback, three consecutive sections per animal were analyzed, starting at a depth of 200 m below the dorsal surface of the spinal cord. The lesion center was identified via characteristic GFAP and/or vimentin staining patterns and then centered using Zeiss LSM 5 Image Browser software. The distance between the ends of five labeled axons projecting farthest into the lesion and the lesion center was then measured. The measurements from all sections from all animals in a group were averaged to yield the average distance of dieback per time point.
Results
We first sought to examine the effects of MAPCs on macrophagemediated axonal dieback using an in vitro system known as a spot assay. This assay involves culturing dissociated adult DRG neurons on an inhibitory gradient of the proteoglycan aggrecan. As DRG neurons that have adhered to the center of the spot extend axons into the gradient, they are met with increasing concentrations of proteoglycan, and concurrently with decreasing amounts of laminin, which results in the formation of dystrophic growth cones at the tips of the axons, a phenomenon that occurs in vivo after spinal cord injury (Tom et al., 2004) . Once axons enter the dystrophic state, they are unable to traverse the most inhibitory outer rim of the substrate and instead remain stalled for extended periods of time, undergoing only slight forward extension or collapse.
To examine the effects of MAPCs on dystrophic axons in the inhibitory gradient, we added adult rat MAPCs to cultures of DRG neurons that had been growing on the spot assay for 24 h (for a schematic of all in vitro experimental paradigms, see supplemental Fig. S1 , available at www.jneurosci.org as supplemental material). After 1 d in coculture, neither adult rat MAPCs nor adult DRG neurons were able to cross the inhibitory spot rim (Fig. 1 B, C) , suggesting that MAPCs were not degrading the proteoglycan substrate. Dystrophic growth cones found within the inhibitory rim typically have a characteristic bulbous, highly vacuolated morphology (Fig. 1 A) . Growth cones of neurons cocultured with MAPCs were quite different, more dynamic and flattened with extensive lamellipodia and filopodia (Fig. 1 D; supplemental Movie 1, available at www.jneurosci.org as supplemental material). Previous work from our laboratory demonstrated that, when dystrophic axons in the inhibitory spot rim are contacted by activated macrophages, they undergo dramatic long-distance retraction, otherwise known as dieback . Activated macrophages form tight, long-lasting adhesions with dystrophic axons that, along with MMP-9 secretion, are necessary for the induction of dieback (Busch et al., 2009 ). We therefore sought to examine the potential effects of coculturing DRG neurons with MAPCs on these phenomena. We selected and imaged dystrophic axons in the inhibitory rim and, after 30 min of baseline observation of growth cone behavior, added NR8383 macrophages to the coculture. Macrophages formed contacts with the axons and growth cones, but these were often transient and were rapidly broken. In the example shown, the growth cone continues to extend further into the inhibitory rim in the presence of MAPCs. Five of the six imaged axons in coculture with MAPCs did not undergo macrophage-mediated axonal retraction (Fig. 1 D-F ) , whereas 100% of dystrophic growth cones typically undergo axonal dieback after macrophage attack . The ability of MAPCs to prevent axonal dieback could be attributable to stimulatory effects on the neuron, modulatory effects on the macrophages, or a combination of both. To address this question, we performed a series of conditioned-medium experiments. In the presence of control medium only, extensive physical interactions occurred between activated macrophages and dystrophic axons resulting in dramatic axonal dieback (N ϭ 6 of 6) ( Fig. 2 A-C) . The growth cone shown here underwent lengthy retraction of ϳ80 m beginning at ϳ30 min after initial macrophage contact, demonstrating that control unconditioned MAPC medium is insufficient to prevent axonal dieback. Direct addition of MAPC-CM to the timelapse dish resulted in a dramatic change in growth cone morphology from a stalled, dystrophic state to a motile, flattened state ( Fig. 3A; supplemental Movie 2, available at www.jneurosci.org as supplemental material). After addition of MAPC-CM, dystrophic axons were able to extend even further into the inhibitory rim and occasionally robust branching was observed (Fig. 3A,C) . Axon extension occurred rapidly after exposure to MAPC-CM, suggesting that the effect is likely independent of transcription (Willis and Twiss, 2006) . Macrophages still contacted these axons but did not induce axonal retraction (Fig. 3A-C) . As a result of this remarkable short-term induction of sprouting and extension, we sought to determine the growth-promoting potential of MAPC-secreted factors over a period of 24 h. We added either MAPC-CM or control medium (CM) to dissociated DRG neurons growing on low levels of laminin and measured the longest neurite on each neuron. We found that MAPC-CM significantly increased sensory neurite outgrowth over CM and basal medium conditions ( p Ͻ 0.0001) (Fig. 4A-C) .
To determine whether MAPCsecreted factors were sufficient to modulate the retraction-inducing capabilities of macrophages, we pretreated macrophages with MAPC-CM for 24 h and then washed the macrophages before their addition to the neuronal cultures on the spot assay. We observed no obvious differences in the ability of MAPC-CM-pretreated macrophages to recognize and associate with dystrophic axons compared with untreated macrophages. Dystrophic axons did not extend significantly further into the inhibitory proteoglycan gradient as they had in the presence of MAPC-CM; however, macrophage-mediated axonal retraction still did not occur (N ϭ 4 of 4) ( Fig. 5A-C ; supplemental Movie 3, available at www.jneurosci.org as supplemental material), indicating that MAPC-secreted factors were modulating the ability of the macrophages to induce dieback. Because macrophages still formed contacts with the axon, it did not appear that their ability to recognize the dystrophic/injured state or adhere to the axon was impaired, but this activity alone was insufficient to induce dieback after pretreatment with MAPCs.
Macrophages are known to secrete a variety of proteases, which aid in the breakdown and clearance of debris after injury (Yong, 2005) . MMPs have been implicated in regeneration failure after CNS injury (Noble et al., 2002) , and work from our laboratory has demonstrated that specific chemical inhibition of macrophage-produced MMP-9 can prevent axonal dieback (Busch et al., 2009 ). We therefore examined the effect of MAPCs on MMP-9 production and secretion from macrophages. We found that coculture with MAPCs dramatically reduced the secretion of both the 105 kDa pro-and 95 kDa activated forms of MMP-9 by macrophages as measured by Western blot ( p Ͻ 0.05) (Fig. 6 A) and levels of functional protein as measured by gelatin zymography ( p Ͻ 0.05) (Fig. 6 B) . Inhibition of MMP-9 proteolytic activity by binding of tissue inhibitor of metalloproteinases (TIMPs) is likely not a factor in the decreased MMP-9 levels observed by Western blot and zymogram, as the denaturing conditions present in these assays would disrupt any existing MMP-9/TIMP protein complexes. Quantitative PCR demonstrated that there was no change in macrophage transcript levels of MMP-9 as a result of coculture with MAPCs (supplemental Fig. S2 , available at www.jneurosci.org as supplemental material). The effect was relatively specific to MAPCs as coculture of macrophages with NG2ϩ progenitor cells did not decrease macrophage MMP-9 secretion (supplemental Fig. S2 , available at www. jneurosci.org as supplemental material).
Recent work has established that secretion of such proinflammatory molecules is reflective of the general activation state of macrophages and is decreased by shifting from an M1, or "classically activated" proinflammatory state, to an M2, or "alternatively activated" antiinflammatory state (Gordon, 2003) . M1 macrophages release cytokines, reactive oxygen species, nitric oxide, and MMPs, whereas M2 macrophages are not neurotoxic, can promote neurite outgrowth (Block et al., 2007; Kigerl et al., 2009) , and exhibit decreased production of a number of proinflammatory molecules, including MMP-9 (Chizzolini et al.,  2000) . There are several markers of M1 and M2 macrophages in vitro and in vivo, some of the most well studied of which are inducible nitric oxide synthase (iNos), a marker of M1 macrophages, and arginase 1 (Arg1), a marker of M2 macrophages (Gordon, 2003; Ghassabeh et al., 2006; Kigerl et al., 2009 ). We therefore examined the effects of MAPC-secreted factors on macrophage expression of iNos and Arg1 transcripts, using a Transwell coculture system. We found that MAPC-secreted factors induced a greater than fivefold increase in the relative ratio of Arg1 to iNos transcript in macrophages (Fig. 6C ), demonstrating that MAPCs are able to induce a shift from a proinflammatory M1 phenotype toward an antiinflammatory M2 phenotype.
We next investigated the effects of MAPCs on axonal dieback in vivo using an adult rat dorsal column crush model of spinal cord injury. The most dramatic phase of axonal dieback occurs between 2 and 7 d after lesion, which correlates spatiotemporally with the infiltration of activated macrophages into the lesion . We hypothesized that MAPCs would modulate activated macrophages and/or stimulate axonal growth within the lesion in such a way as to reduce the extent of axonal dieback and/or promote regeneration. Therefore, we transplanted MAPCs into the dorsal columns of the spinal cord immediately after injury and measured the extent of axonal dieback at 2, 4, and 7 d after lesion. MAPCs were transplanted ϳ500 m caudal to the lesion and 500 m lateral to the midline to prevent the cells from being displaced from the spinal cord by blood and CSF flow directly at the lesion site. MAPCs survived in large numbers when transplanted in the acute post lesion interval but were ultimately cleared by 28 d after injury (data not shown), enabling the cells to effect the lesion environment for some time, while minimizing the risk of any remaining cells contributing to ectopic tissue formation or aberrant physiology.
Transplanted MAPCs migrated extensively from the site of transplantation into the core of the lesion and were observed to associate with the endings of injured axons ( Fig. 7B ; supplemental Fig. S4 , available at www.jneurosci.org as supplemental material). By 2 d after lesion, macrophages were not yet present in the lesion in significant numbers, but labeled axons did not extend to the edge of the lesion. This suggests that an initial, intrinsic, macrophage-independent phase of dieback occurs during this time, which has previously been demonstrated by Kerschensteiner et al. (2005) . Accordingly, the extent of axonal dieback in MAPC-transplanted animals was similar to that observed in vehicle control-treated animals at 2 d after lesion (Fig. 7C) . By 4 d after lesion, MAPC-transplanted animals showed a significant decrease in the extent of axonal dieback compared with vehicle controls ( p Ͻ 0.02) (Fig. 7C) . This is consistent with the idea that transplanted MAPCs attenuated the extent of axonal dieback that would normally occur at this time. Interestingly, MAPCtransplanted animals had decreased numbers of ED1ϩ cell profiles in the lesion core at both 4 and 7 d after lesion ( p Ͻ 0.01) (Fig.  7D) . By 7 d after lesion, injured axons in MAPC-transplanted animals had regenerated into the lesion center, whereas axons in vehicle control-treated animals did not ( p Ͻ 0.00001) (Fig.  7A-C) . In animals receiving MAPC transplants, we even observed fibers extending beyond the midpoint of the lesion at Fig. S4 , available at www.jneurosci. org as supplemental material), providing additional evidence of the trophic and axon growth-supporting properties of this cell population.
To determine whether this result was attributable to common secreted factors and could be recapitulated by any cell type, we examined the effects of rat astrocyte transplants on axonal dieback at 7 d after injury. We chose to transplant astrocytes as they are resident CNS cells found in the lesion environment that do not induce axonal dieback in vitro . We found that astrocytes transplanted just outside the lesion also survived within the acute injury environment, but did not migrate extensively into the lesion core and were not able to prevent axonal dieback at 7 d after injury (supplemental Fig. S5 , available at www.jneurosci.org as supplemental material). This suggests that our results with MAPCs are not simply the result of the physical presence of any cell type transplanted into the lesion.
Discussion
It was originally thought that transplantation of stem cells in the CNS would have beneficial effects primarily through replacement of damaged neuronal circuitry or promotion of reparative activities such as replenishment of lost oligodendrocytes and subsequent remyelination (Keirstead et al., 2005) . However, several studies have found that, without manipulation, transplanted stem cells predominantly give rise to astrocytes, and limited numbers of oligodendrocytes and neurons (Hofstetter et al., 2005; Enzmann et al., 2006; KarimiAbdolrezaee et al., 2010) . More recently, there is increasing evidence that transplanted adult stem cells tend to remain undifferentiated and often are cleared after a short time, but still promote recovery (Parr et al., 2007) . This suggests that their beneficial effects are mediated primarily through paracrine activities that impact host tissues. This has been attributed to mechanisms involving release of factors that are neuroprotective (Parr et al., 2007) , angiogenic (Onda et al., 2008) , and/or immunomodulatory (Ohtaki et al., 2008; Abrams et al., 2009; Boucherie and Hermans, 2009) . In this study, we have provided evidence that MAPCs can modulate macrophage responses to CNS injury and induce neurite outgrowth in vitro and, in turn, prevent the deleterious phenomenon of axonal dieback and promote regrowth after spinal cord injury.
Many previous experimental efforts to promote regeneration in the CNS have focused on eliminating or overcoming the barriers to regeneration individually through several approaches including the following: removal of inhibitors within the extracellular matrix , addition of growth factors (Alto et al., 2009) , modification of the inflammatory response to injury Gensel et al., 2009) , as well as administration of conditioning lesions or placement of bridges to stimulate or direct the intrinsic growth capacity of neurons (David and Aguayo, 1981; Neumann and Woolf, 1999; Houle et al., 2006; Park et al., 2008) . More recently, it has been demonstrated that combinatorial strategies that target the numerous mechanisms involved in regeneration failure produce the best outcomes (Pearse et al., 2004; Kadoya et al., 2009 ). Here, we have shown that MAPCs can positively alter both the low intrinsic growth state of dystrophic adult sensory axons as well as the inflammatory response after injury to simultaneously prevent deleterious axonal dieback and promote neurite outgrowth and sprouting. Although the rescue of axonal dieback in MAPC-treated animals is spatially and temporally correlated with macrophage infiltration, and elimination of infiltrating macrophages has previously been shown to prevent axonal dieback during this time , we have not directly proven in this study that modulation of macrophage activity was the primary mechanism of action of MAPCs in the spinal cord. MAPCs could also influence axon outgrowth by altering other components of the lesion environment such as the glial scar through modification of astrocyte reactivity, possibly as a secondary effect of immunomodulation (Fitch et al., 1999) . Additionally, production of trophic factors such as VEGF (vascular endothelial growth factor) by MAPCs ( Van't Hof et al., 2007) could be contributing to a positive outcome by enhancing cell survival or promoting the recruitment and/or proliferation of endogenous progenitor cells (Engel and Wolswijk, 1996; Sasaki et al., 2009; Thau-Zuchman et al., 2010) , which have been shown to provide a permissive substrate for regenerating axons (McTigue et al., 2001; Jones et al., 2003; Yang et al., 2006; Busch et al., 2010) . Despite the fact that astrocytes were unable to prevent axonal dieback, we do not intend to suggest that these results will be unique to MAPC transplants. This will require extensive additional studies, and it is likely that other cell types will have the capacity to accomplish one or both to some extent. However, to our knowledge, this is the first demonstration of an adult stem cell capable of modulating a multiplicity of detrimental macrophage and neuronal behaviors concurrently.
Here, we have demonstrated that MAPCs can alter the inflammatory response to prevent, at least in part, deleterious secondary injury in the CNS. MAPC coculture with macrophages inhibits macrophage secretion of the protease MMP-9, which we have previously shown to be responsible, in part, for macrophage-induced axonal dieback (Busch et al., 2009 ). There are multiple stages of macrophage MMP-9 production and processing that could be impacted by MAPCs, including transcription, translation, secretion, activation, and inhibition by TIMPs. MAPC coculture could affect macrophage MMP-9 activity at any one, or more, of these levels. However, our data clearly demonstrate that MMP-9 transcription is not affected by MAPC coculture, as macrophage MMP-9 mRNA levels were unchanged in the presence of MAPCs compared with control conditions. Our data also indicate that activation of pro-MMP-9 is not affected by MAPC coculture, as both the pro-and activated forms of MMP-9 protein are proportionally decreased after coculture as seen by Western blot. Interestingly, TIMP-mediated inhibition might represent a secondary level at which MAPCs could further affect MMP-9 activity in dieback assays or in vivo, as MAPCs express high levels of TIMP-1 (data not shown). Nevertheless, our data indicate that MAPC coculture significantly reduced the amount of MMP-9 protein released by the cells, suggesting a direct effect on MMP-9 secretion. We have demonstrated the effects of MAPCs on MMP-9 activity and M1/M2 activation state markers; however, MAPCs may also alter expression of other MMPs and/or other proinflammatory molecules (Kigerl et al., 2009) . Although MMPs are produced by both M1 and M2 macrophages, M2 macrophages have been shown to secrete MMP1 and MMP12, which favor substrate remodeling, and to downregulate MMP-9 (Gordon, 2003). A more detailed investigation of the effects of MAPCs on these processes will be required to fully understand the under- (1, 66) ϭ 31.60). Day 2 vehicle control is significant from day 7 vehicle control; day 2 MAPC is significant from day 7 MAPC; day 4 vehicle control is significant from day 4 MAPC-treated and day 7 MAPC-treated groups; day 7 vehicle control group is significant from day 4 MAPC and day 7 MAPC groups by Tukey's post hoc test, # p Ͻ 0.01, *p Ͻ 0.02, **p Ͻ 0.001, ***p Ͻ 0.0001. D, Graphical representation of ED1ϩ immunoreactivity in the center of the lesion at 2, 4, and 7 d after injury in animals receiving vehicle only or MAPC transplants. The conditions, vehicle control and MAPC-treated groups, are significantly different from one another ( p Ͻ 0.01; two-way ANOVA, F (1,66) ϭ 7.05). Error bars indicate SEM. Scale bars: A, B, 200 m. lying mechanism(s) and determine that these changes are also occurring in vivo. In the present study, we have laid the groundwork to examine this and other in vitro and in vivo pathways through which adherent stem cells control the macrophage inflammatory response to dystrophic neurons and the greater inflammatory environment.
MAPCs could have similar effects in other CNS injuries in which secondary injury has dire consequences, as has been suggested by other work (Zhao et al., 2002; Yasuhara et al., 2008) . In the white matter of the dorsal columns, additional functional loss caused by dieback is not always evident unless axons retract past many collateral branch points (Seif et al., 2007) . After ischemic lesion to the cortex, cortical projection fibers retract dramatically into white matter (A. L. Hawthorne and J. Silver, unpublished observations). Our results may therefore be particularly relevant after ischemic stroke, as regulating the extent of dieback in gray matter could significantly alter outcome. It is important to consider the spectrum of reparative pathways that can be engaged using cell therapy, particularly in light of many failed single modality approaches in stroke (Fisher et al., 2005) . MAPCs could promote maintenance of cortical association as well as other types of fibers at the lesion edge, providing an enriched, synaptically connected lesion penumbra and an anatomical substrate for functional recovery.
Although significant work remains before these results can be translated to human therapy, it is exciting that several well characterized mechanistic pathways that mediate regeneration failure after spinal cord injury can be modified by a stem cell population. An allogeneic adult human bone marrow-derived stem cell, which uses MAPC growth conditions and is expanded under good manufacturing practice regulations, has already received allowance by the Food and Drug Administration for clinical investigation in the treatment of several indications, including ischemic stroke. Although combinatorial strategies using drugs or biologics are feasible, the dynamic and multimodal response of therapeutic stem cells to the injury environment may provide a safe and effective cellular therapy for spinal cord injury as well as other neurological indications.
